Cannabinoids, the active components of marijuana and their derivatives, are currently
investigated due to their potential therapeutic application for the management of many …

Temozolomide is an oral alkylating agent that is used as the first line treatment for
glioblastoma multiform, and in recurrent anaplastic astrocytoma, as well as having …

It has been shown that leukemia and glioma cells are sensitive to cannabidiol (CBD)-
induced apoptosis, whereas primary monocytes and glia cells are relatively insensitive. In …

Glioblastoma (GBM) is the most common and aggressive primary brain tumor. Effective
treatment for GBM is limited by the presence of the blood–brain barrier (BBB) and low …

Melanoma is one of the leading fatal forms of cancer, yet from a treatment perspective, we
have minimal control over its reoccurrence and resistance to current pharmacotherapies …

Cannabinoids include the active constituents of Cannabis or are molecules that mimic the
structure and/or function of these Cannabis-derived molecules. Cannabinoids produce …

Despite the extensive efforts to find effective therapeutic strategies, glioblastoma (GBM)
remains a therapeutic challenge with dismal prognosis of survival. Over the last decade the …

We recently reported that cannabidiol (CBD) exhibited a generalized suppressive effect on T-
cell functional activities in splenocytes directly exposed to CBD in vitro or isolated from CBD …

Radiotherapy combined with chemotherapy is the major treatment modality for human
glioblastoma multiforme (GBM). GBMs eventually relapse after treatment and the average …

Simple Summary Phytocannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol
(CBD) have been demonstrated to exhibit anti-cancer activity in preclinical models of brain …